Ferreira, Ana Maria da Costa 
; Stock, Regine Schneider; Aiello, Francesca
Source: Frontiers in Molecular Biosciences. Unidade: IQ
Subjects: ANTINEOPLÁSICOS, METABOLÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Ana Maria da Costa e STOCK, Regine Schneider e AIELLO, Francesca. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial]. Frontiers in Molecular Biosciences. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fmolb.2022.859821. Acesso em: 19 nov. 2024. , 2022APA
Ferreira, A. M. da C., Stock, R. S., & Aiello, F. (2022). Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial]. Frontiers in Molecular Biosciences. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fmolb.2022.859821NLM
Ferreira AM da C, Stock RS, Aiello F. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial] [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-2 art. 859821.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmolb.2022.859821Vancouver
Ferreira AM da C, Stock RS, Aiello F. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial] [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-2 art. 859821.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmolb.2022.859821
